When using semaglutide, pay attention to GI adverse effects
Liver Function Support: Its ability to inhibit glucagon release results in decreased hepatic glucose production, a feature that is integral for maintaining stable blood sugar levels
And one thing I've come to understand deeply as both a surgeon and a medical weight-loss physician is that the human body has its own built-in hormonal machinery for controlling hunger and fat storage
Variants in the GLP1R gene (such as rs6923761) and FTO gene (rs9939609) may alter receptor sensitivity and gastrointestinal hormone signaling, potentially affecting the intensity of nausea or indigestion during treatment initiation
Adding a GLP-1 receptor agonist as a coadjutant therapy in the early post-transplant period to the appropriate patient brings good metabolic outcomes and also is safe, Mario Campana, MD, fellow in the division of endocrinology, diabetes and metabolism at the Heersink School of Medicine at the University of Alabama at Birmingham (UAB), told Healio